Liberty Wealth Management LLC Has $200,000 Stock Position in Phreesia, Inc. (NYSE:PHR)

Liberty Wealth Management LLC lifted its stake in Phreesia, Inc. (NYSE:PHR) by 6,030.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,260 shares of the company’s stock after buying an additional 12,060 shares during the period. Liberty Wealth Management LLC’s holdings in Phreesia were worth $200,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Stephens Inc. AR increased its position in shares of Phreesia by 2.1% during the 2nd quarter. Stephens Inc. AR now owns 8,179 shares of the company’s stock worth $501,000 after purchasing an additional 165 shares in the last quarter. Ameritas Investment Partners Inc. grew its stake in Phreesia by 7.4% during the second quarter. Ameritas Investment Partners Inc. now owns 2,989 shares of the company’s stock worth $183,000 after buying an additional 205 shares during the last quarter. PDT Partners LLC increased its holdings in shares of Phreesia by 1.8% during the first quarter. PDT Partners LLC now owns 14,060 shares of the company’s stock worth $733,000 after buying an additional 242 shares in the last quarter. Nisa Investment Advisors LLC raised its stake in shares of Phreesia by 20.0% in the second quarter. Nisa Investment Advisors LLC now owns 1,740 shares of the company’s stock valued at $107,000 after acquiring an additional 290 shares during the last quarter. Finally, Fifth Third Bancorp boosted its holdings in shares of Phreesia by 44.9% in the 2nd quarter. Fifth Third Bancorp now owns 1,440 shares of the company’s stock worth $88,000 after acquiring an additional 446 shares in the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

A number of equities research analysts recently weighed in on PHR shares. Raymond James raised their price target on Phreesia from $65.00 to $75.00 and gave the company an “outperform” rating in a report on Friday, September 3rd. Robert W. Baird lifted their price target on Phreesia from $62.00 to $67.00 and gave the company an “outperform” rating in a report on Friday, September 3rd. JPMorgan Chase & Co. upped their price target on shares of Phreesia from $64.00 to $68.00 and gave the stock an “overweight” rating in a research report on Thursday, June 17th. JMP Securities began coverage on shares of Phreesia in a research report on Tuesday, July 13th. They issued an “outperform” rating and a $80.00 price objective for the company. Finally, KeyCorp boosted their target price on shares of Phreesia from $70.00 to $73.00 and gave the stock an “overweight” rating in a research note on Monday, July 12th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, Phreesia presently has an average rating of “Buy” and a consensus target price of $69.10.

In other Phreesia news, SVP David Linetsky sold 4,978 shares of the firm’s stock in a transaction dated Wednesday, September 1st. The stock was sold at an average price of $70.42, for a total transaction of $350,550.76. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Chaim Indig sold 57,556 shares of the company’s stock in a transaction dated Friday, August 27th. The shares were sold at an average price of $72.29, for a total value of $4,160,723.24. The disclosure for this sale can be found here. In the last three months, insiders sold 181,368 shares of company stock worth $12,804,059. 5.60% of the stock is currently owned by company insiders.

Shares of NYSE:PHR opened at $62.55 on Thursday. Phreesia, Inc. has a one year low of $30.50 and a one year high of $81.59. The company has a 50 day moving average of $66.00 and a 200-day moving average of $59.33. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.56 and a quick ratio of 8.56. The stock has a market cap of $3.18 billion, a price-to-earnings ratio of -58.46 and a beta of 1.21.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Tuesday, August 31st. The company reported ($0.48) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.26). Phreesia had a negative net margin of 27.94% and a negative return on equity of 13.18%. The business had revenue of $51.01 million during the quarter, compared to the consensus estimate of $47.22 million. During the same period in the previous year, the business posted ($0.17) earnings per share. Phreesia’s revenue was up 45.7% compared to the same quarter last year. Equities research analysts anticipate that Phreesia, Inc. will post -1.38 earnings per share for the current year.

Phreesia Profile

Phreesia, Inc is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products.

See Also: Trading Strategy Methods and Types

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR).

Institutional Ownership by Quarter for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.